New fund · Healthcare & Life Sciences

W Health Ventures closes fund ii at rs 550 crore first close

By Startup Enthusiast · 12 February 2026

What they do

W Health Ventures is an early-stage healthcare-focused venture capital firm with a company creation model

It announced the first close of Fund II at Rs 550 crore, targeting Rs 630 crore, to build 8-10 startups over four years

Fund I portfolio includes BeatO, Wysa, and Mylo; Fund II's first startup is Everhope Oncology with Narayana Health

W Health Ventures announced the first close of its Fund II at Rs 550 crore.
The fund's target is Rs 630 crore.
The fund will build and scale 8 to 10 new startups over 4 years.
It plans to invest Rs 30-50 crore per incubation.
The first startup from Fund II is Everhope Oncology, a national oncology platform in partnership with Narayana Health.
Another stealth incubation is helping US psychiatry clinics launch advanced treatments for treatment-resistant depression.
The fund is also exploring longevity, modern preventive health, geriatrics, and chronic pain management.

W Health Ventures' Fund I portfolio includes BeatO (diabetes), Wysa (AI mental health), and Mylo (parenting).
Its portfolio companies have impacted over 25 million individuals globally.
The firm uses a company creation model in India and the US-India corridor.

W Health Ventures is an early-stage healthcare-focused venture capital firm.
It uses a company creation model to build startups in India and the US-India corridor.
It has offices in Boston, Delhi, Mumbai, and Bangalore.
It has deployed $65M+ across 14 portfolio companies.
All portfolio companies have raised downstream capital.
Its portfolio companies have reached 25M+ patients.

Build and scale 8 to 10 new startups over 4 years.
Invest Rs 30-50 crore per incubation.
Explore longevity, modern preventive health, geriatrics, and chronic pain management.